Delivery Order SPE2DB22D1002-SPE2DB24FLAV4
Award Date
4/16/24
Potential Completion Date
4/17/24
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of RabAvert rabies vaccine with diluents. The award, valued at $2,702.42, is a firm fixed price delivery order contract with a completion date of March 26, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. In addition to this specific award, Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a pharmaceutical distribution and healthcare solutions provider, for the delivery of RabAvert rabies vaccine with diluents. The contract, valued at $25,800.60, is a firm fixed-price delivery order with a completion date of June 5, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of RabAvert rabies vaccine with diluents. The fixed-price delivery order has a ceiling value of $1,930.30 and an ultimate completion date of April 23, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the supply of RABAVERT RABIES VACCINE with diluents to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The $3,088.48 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract has an ultimate completion date of April 26, 2024 and does not have a set-aside designation....
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of RABAVERT rabies vaccine with diluents. The contract, valued at $2,095.80, is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of March 14, 2025 and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract for $5,790.90 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply RabAvert rabies vaccine with diluents. This contract has a completion date of February 12, 2024 and is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor and has previously received numerous federal contract awards from DLA to provide pharmaceuticals, medical supplies, and...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, is for the delivery of RABAVERT rabies vaccine with diluents. The $1,737.27 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. No set-aside designations were used. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of RABAVERT rabies vaccine with diluents, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The $3,860.60 firm fixed price delivery order has a completion date of November 1, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026 to provide a comprehensive range of medical commodities,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of RabAvert rabies vaccine with diluents. The contract has a ceiling value of $38,606.00 and a period of performance through April 23, 2024. The contract type is a delivery order, with a firm fixed price pricing structure. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply RabAvert rabies vaccine with diluents. The contract, valued at $24,552.90, has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp is the prime contractor, with no set-aside designation indicated. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded by DLA to...